6th Cell and Gene Patient Engagement Therapy Summit

The 6th Cell and Gene Patient Engagement Therapy Summit explores innovative strategies to enhance patient engagement, education, and advocacy in cell and gene therapy development and delivery.

Key Topics

• Understanding how to optimize the collaboration between patient engagement and clinical operations to recruit and retain ideal cohort
• Evaluating best practice for patient engagement and advocacy for effective and patient centric collaboration
• Exploring the innovative methods of cell and gene therapy education to improve patient awareness
• Demonstrating new digital education tools for CAR-T to support shared decision making in cell therapy
• Learning how to create a coalition to cultivate state policy change
• Collaborating with patient groups to tell the right story to payers and insurance companies
• Integrating methods for early patient participation to optimize for a patient-therapy fit
• Maximizing patient education and collaboration during research and development to support patient preparation to receive a therapy
• Utilizing patient involvement to achieve regulatory approval
• Driving for better patient experience throughout patient journey to optimize for patient retention
• Audience workshop: spearheading new approaches in quantifying cell and gene therapy patient engagement to showcase patient engagement’s critical value
• Understanding the differences between prevalent and rare diseases to optimize tailored patient educational materials
• Exploring the value of patients voices to inform the development process and future probability of therapeutic access
• Parent interview session: exploring how patients decide on joining cell and gene clinical trials to optimize for better decision-making tools
• Debating whether patient organization leaders should be involved in regulatory meetings to optimize patient transparency
• Addressing the practical needs of patients during long-term follow ups to ensure patient retention
• Investigating new strategies using patient voices to increase therapeutic access
• Optimizing healthcare readiness and treatment experiences to assist patients throughout treatment journey

Who should Attend

• Patient advocacy leaders
• Clinical operations professionals
• Biotech and pharma executives in cell and gene therapy
• Health policy advisors
• Regulatory affairs specialists
• Patient experience and support managers
• Digital health and education tool developers
• Medical affairs and R&D teams